NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma
Andrea M. Griesinger(Morgan Adams Foundation), Nicholas K. Foreman(Morgan Adams Foundation), Sydney Grob(Morgan Adams Foundation), Bridget Sanford(University of Colorado Denver), Ilango Balakrishnan(Morgan Adams Foundation), Michael H. Handler(Children's Hospital Colorado), Sujatha Venkataraman(University of Colorado Anschutz Medical Campus), John DeSisto(Morgan Adams Foundation), Davis Witt(Morgan Adams Foundation), Andrew M. Donson(Children's Hospital Colorado), Sabrina R Georgio Westover(Morgan Adams Foundation), Lindsey M. Hoffman(St Nicholas Hospital), Jean M. Mulcahy Levy, Kenneth L. Jones(University of Colorado Anschutz Medical Campus), Daniel C. Moreira(St. Jude Children's Research Hospital), Randall Wong(Morgan Adams Foundation), Rajeev Vibhakar(Children's Hospital Colorado)
Cited by 23
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|654
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries
|Journal of Clinical Oncology|2018|433
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345